阿加曲班治疗发病6?h以上急性脑梗死患者的临床效果分析

Clinical Effect of Agacopan on Acute Cerebral Infarction Patients with More than 6 Hours of Onset

目的观察阿加曲班治疗发病6小时以上急性脑梗死患者的临床效果。方法选取2016年7月5日至2017年11月3日本院收治的发病6小时以上的急性脑梗死患者100例为研究对象,随机分为两组,各50例。对照组患者进行常规治疗,观察组患者联合阿加曲班治疗,观察比较两组疗效及NIHSS评分。结果观察组急性脑梗死患者经阿加曲班治疗的治疗总好转率为86.00%,NIHSS评分为(3.16±2.73)分,评分减少值为(2.61±2.45)分,均显著优于对照组(P<0.05)。结论阿加曲班治疗发病6小时以上急性脑梗死患者,可明显改善神经功能缺损情况。

Objective To study and determine the clinical effect of acagtran in the treatment of patients with acute cerebral infarction for more than 6 hours of onset. Methods From July 2016 to November 2017, 100 patients with acute cerebral infarction with more than 6 hours of onset were randomly divided into two groups, each with 50 cases. The patients in the control group were treated with conventional therapy, and the patients in the observation group were treated with AGA trban.Treatment effect and NIHSS score were compared between groups. Results The total improvement rate of ACI treated patients in the observation group was 86%, the NIHSS score was(3.16+2.73), and the score reduction was(2.61+2.45) scores, which were all better than those of the control group(P<0.05). Conclusion The clinical effect of acaciban therapy for patients with acute cerebral infarction more than 6 hours is significant, and it can obviously improve the condition of nerve function defect.